Literature DB >> 20407319

Natural history of biologically malignant struma ovarii: analysis of 27 cases with extraovarian spread.

Ruthy Shaco-Levy1, Sarah M Bean, Rex C Bentley, Stanley J Robboy.   

Abstract

The natural history of 27 cases of biologically malignant struma ovarii from a series of 88 cases of histologically malignant or histologically proliferative struma ovarii is described. The extraovarian spread was evident at presentation in 17 patients. The malignant nature of the other 10 tumors became apparent only after they recurred. The tumors measured 5 to 24.5 cm and were more than 50% thyroid tissue in all but 2 cases. The microscopic diagnosis of the thyroid tissue was follicular adenoma in 17 cases (63%), papillary carcinoma in 7 (26%), unremarkable in 2 (7%), and follicular carcinoma in 1 case (4%). Generally, the clinical course was protracted, with long-term survival documented in most patients. Clinical features predictive of biologic malignancy were the presence of adhesions, peritoneal fluid (> or = 1 L), or a serosal rent in the struma ovarii (including cystectomy). In addition, pathologic factors predictive of a poorer prognosis were large size (> or = 10 cm), strumal component more than 80%, and extensive papillary carcinoma, especially with solid areas, necrosis, and > or = 5 mitoses per 10 high-power fields. Follow-up for all patients was 1.5 to 33 years (mean=13.5 yr). On last follow-up 3 patients (11%) had no evidence of disease, 9 (33%) were alive with disease, 5 (19%) died of other causes, and 10 patients (37%) died of the disease. Death from disease occurred 1.5 to 32 years after diagnosis (mean=14 yr). Recurrence was seen as early as 2 months and as late as 29 years after initial surgery (mean=7 yr). Long-term follow-up is indicated in patients with any of the above-mentioned adverse indicators.

Entities:  

Mesh:

Year:  2010        PMID: 20407319     DOI: 10.1097/PGP.0b013e3181bfb133

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  17 in total

1.  Struma ovarii. A case report.

Authors:  P Tanimanidis; K Chatzistamatiou; A Nikolaidou; K Kaplanis
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

2.  Papillary thyroid-type carcinoma arising from struma ovarii.

Authors:  Jerome Rebollos Barrera; Leonido Andrade Manalo; Frances Lina Lantion Ang
Journal:  BMJ Case Rep       Date:  2012-07-11

3.  Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis.

Authors:  Hyun-Soo Kim; Gun Yoon; Yoo-Young Lee; Tae-Joong Kim; Chel-Hun Choi; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae; Sang Yong Song
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Malignant Clinical Course of "Proliferative" Ovarian Struma: Diagnostic Challenges and Treatment Pitfalls.

Authors:  Aleksandra Asaturova; Alina Magnaeva; Anna Tregubova; Vlada Kometova; Yevgeniy Karamurzin; Sergey Martynov; Yuliya Lipatenkova; Leila Adamyan; Andrea Palicelli
Journal:  Diagnostics (Basel)       Date:  2022-06-07

5.  Metastatic follicular struma ovarii complicating pregnancy: a case report and review of the literature.

Authors:  Woohyung Lee; Nam-Joon Yi; Hyeyoung Kim; Youngrok Choi; Minsu Park; Geun Hong; June Young Choi; Hyun Hoon Chung; Kwang-Woong Lee; Do-Joon Park; Hye Sook Min; June-Key Chung; Kyung-Suk Suh
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-08-31

6.  Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii.

Authors:  A Tan; C J R Stewart; K L Garrett; M Rye; P A Cohen
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

7.  Malignant Struma Ovarii Τreated With Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Miklos Acs; Sebastian Häusler; Hamid-Reza Lighvani; Jozef Zustin; Pompiliu Piso
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

8.  Poorly Differentiated Thyroid Carcinoma Arising in Struma Ovarii.

Authors:  Surapan Khunamornpong; Jongkolnee Settakorn; Kornkanok Sukpan; Prapaporn Suprasert; Sumalee Siriaunkgul
Journal:  Case Rep Pathol       Date:  2015-06-21

9.  Late Bone Metastasis of Histologically Bland Struma Ovarii: The Unpredictability of Its Biologic Behavior.

Authors:  Sun-Ju Oh; Minjung Jung; Young-Ok Kim
Journal:  J Pathol Transl Med       Date:  2015-07-15

Review 10.  Treatment for malignant struma ovarii in the eyes of thyroid surgeons: a case report and study of Chinese cases reported in the literature.

Authors:  Jiang-Rong Luo; Chun-Bao Xie; Zhi-Hui Li
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.